Stay Hydrated Throughout the Day Vomiting, diarrhea, reduced appetite, and constipation may all increase the risk of dehydration
Toujeo (Insulin Glargine) Toujeo 2022 sales: $1.225 billion Company/Developer: Sanofi Date of first FDA approval: February 25, 2015 Indications Toujeo is FDA-approved for: Toujeo is a long-acting human insulin analog prescribed to enhance glycemic control in adults and pediatric patients aged six years and older with diabetes mellitus
Country Comparison United States vs Mexico and Canada In all three countries, Jardiance is available in similar dosage forms, typically as oral tablets
GLP-1s affect appetite, digestion and blood sugar response
The duration of the trials ranged from four weeks to 36 months and the comparison groups were given either a placebo or a multivitamin without vitamin K
Genomics 18 , 99107 (2008)